Sandbox Wabash 06 Fumarase
From Proteopedia
(Difference between revisions)
Line 5: | Line 5: | ||
== Debate == | == Debate == | ||
- | Two mutant forms of fumarase C from E. coli have been made using PCR and recombinant DNA. Two different carboxylic acid binding sites (A+B) were observed in the crystal structures of the WT inhibited forms of the enzyme. The <scene name='72/726382/H188n/1'>H188N mutant </scene>has L-malate bound at active site A. | + | <scene name='72/726382/His188_and_his129/1'>Two mutant forms</scene>of fumarase C from E. coli have been made using PCR and recombinant DNA. Two different carboxylic acid binding sites (A+B) were observed in the crystal structures of the WT inhibited forms of the enzyme. The <scene name='72/726382/H188n/1'>H188N mutant </scene>has L-malate bound at active site A. |
Crystallographic studies with several inhibitors including pyromellitic acid and B-trimethylsilyl maleate yielded interesting results. While both inhibitors are related to the normal substrate, each was found bound at different sites. The binding site of inhibitors citrate and pyromellitic acid was deemed the A site while a second site containing L-malate and B-trimethylsilyl maleate was labeled as the B-site. The first argument for site A being the active site was that the A site was formed by 3 of the 4 subunits. Secondly, citrate was used at high concentrations as a crystallizing agent and is known to competitively inhibit fumarase. As such, in X-ray studies, citrate was not able to be removed readily from the specimen preparation and it pointed to the A site. In regards to the B site, it was first noted that atoms of a single subunit formed the B site. Strong arguments were then made against the B site as no active monomeric form of fumarase has ever been described. | Crystallographic studies with several inhibitors including pyromellitic acid and B-trimethylsilyl maleate yielded interesting results. While both inhibitors are related to the normal substrate, each was found bound at different sites. The binding site of inhibitors citrate and pyromellitic acid was deemed the A site while a second site containing L-malate and B-trimethylsilyl maleate was labeled as the B-site. The first argument for site A being the active site was that the A site was formed by 3 of the 4 subunits. Secondly, citrate was used at high concentrations as a crystallizing agent and is known to competitively inhibit fumarase. As such, in X-ray studies, citrate was not able to be removed readily from the specimen preparation and it pointed to the A site. In regards to the B site, it was first noted that atoms of a single subunit formed the B site. Strong arguments were then made against the B site as no active monomeric form of fumarase has ever been described. |
Revision as of 06:03, 29 February 2016
Mutations in Fumerase Active Site
|
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ Weaver T, Lees M, Banaszak L. Mutations of fumarase that distinguish between the active site and a nearby dicarboxylic acid binding site. Protein Sci. 1997 Apr;6(4):834-42. PMID:9098893
- ↑ Weaver T, Lees M, Banaszak L. Mutations of fumarase that distinguish between the active site and a nearby dicarboxylic acid binding site. Protein Sci. 1997 Apr;6(4):834-42. PMID:9098893
- ↑ Weaver T, Lees M, Banaszak L. Mutations of fumarase that distinguish between the active site and a nearby dicarboxylic acid binding site. Protein Sci. 1997 Apr;6(4):834-42. PMID:9098893